GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Albemarle Corp (NYSE:ALB) » Definitions » Change In Payables And Accrued Expense

ALB (Albemarle) Change In Payables And Accrued Expense : $0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Albemarle Change In Payables And Accrued Expense?

Albemarle's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was $0 Mil. It means Albemarle's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

Albemarle's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was $-30 Mil. It means Albemarle's Accounts Payable & Accrued Expense declined by $30 Mil from Dec. 2022 to Dec. 2023 .


Albemarle Change In Payables And Accrued Expense Historical Data

The historical data trend for Albemarle's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albemarle Change In Payables And Accrued Expense Chart

Albemarle Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.87 -246.53 271.01 1,085.72 -29.89

Albemarle Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Albemarle Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albemarle Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Albemarle's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Albemarle Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Albemarle Corp (NYSE:ALB) » Definitions » Change In Payables And Accrued Expense
Address
4250 Congress Street, Suite 900, Charlotte, NC, USA, 28209
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Executives
Netha N. Johnson officer: President, Bromine Specialties 3489 CRESTMOOR DRIVE, WOODBURY MN 55125
Barichivich John Clarence Iii officer: VP, Controller & CAO 4250 CONGRESS ST., SUITE 900, CHARLOTTE NC 28209
Kristin M Coleman officer: EVP, General Counsel 140 HAZEL AVE., GLENCOE IL 60022
Neal Ravi Sheorey officer: Chief Financial Officer 4250 CONGRESS STREET, SUITE 900, CHARLOTTE NC 28209
Michael James Simmons officer: President - Ketjen 301 COMMERCE STREET, SUITE 3200, FORT WORTH TX 76102
Eric Norris officer: President, Lithium 1519 AUDUBON ROAD, CHARLOTTE NC 28211
J Kent Masters director ALBEMARLE CORP., 451 FLORIDA ST, BATON ROUGE LA 70801
Sean B. O'hollaren officer: Chief External Affairs Officer 4250 CONGRESS STREET, SUITE 900, CHARLOTTE NC 28209
Jacobus G. Fourie officer: Chief Capital Projects Officer 4250 CONGRESS STREET, SUITE 900, CHARLOTTE NC 28209
Scott Tozier officer: EVP & CFO ALBEMARLE CORP, 4250 CONGRESS ST STE 900, CHARLOTTE NC 28209
Karen G Narwold officer: EVP, Chief Admin Officer ALBEMARLE CORPORATION, 4250 CONGRESS ST, SUITE 900, CHARLOTTE NC 28209
Raphael Goszcz Crawford officer: President, Catalysts 4311 GREENBRIAR HILLS PLANTATION RD, CHARLOTTE NC 28277
Ralf Hans Cramer director MIERENDORSFSTRASSE 26, BENSHEIM 2M 64625
Kissam Luther C Iv director, officer: Chairman, President & CEO 3801 BERESFORD ROAD, CHARLOTTE NC 28211
Melissa H. Anderson officer: SVP, Chief HR Officer ALBEMARLE CORPORATION, 4250 CONGRESS ST. SUITE 900, CHARLOTTE NC 28209